Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-07-30 Purchase |
2021-08-03 9:06 pm |
DA32 Life Science Tech Acquisition Corp. | DALS | ARCH Venture Fund XI L.P. ARCH Venture Partners XI L.P. ARCH Venture Partners XI LLC NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner |
1,600,000 | $10 | $16,000,000 | 4,500,000 (Indirect Direct) |
View |
| 2020-09-18 Purchase |
2020-09-22 11:09 am |
Metacrine Inc. | MTCR | Burow Kristina Director |
230,000 | $13 | $2,990,000 | 158,734 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-08-05 Other |
2021-08-09 8:31 pm |
N/A N/A |
DA32 Life Science Tech Acquisition Corp. | DALS | ARCH Venture Fund XI L.P. ARCH Venture Partners XI L.P. ARCH Venture Partners XI LLC NELSEN ROBERT Burow Kristina GILLIS STEVEN Member of 10% owner group 10% Owner |
701,250 | $0 | 4,465,000 (Indirect) |
View |
| 2021-07-30 Other |
2021-08-03 9:06 pm |
N/A N/A |
DA32 Life Science Tech Acquisition Corp. | DALS | ARCH Venture Fund XI L.P. ARCH Venture Partners XI L.P. ARCH Venture Partners XI LLC NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner |
650,000 | $10 | 4,500,000 (Indirect) |
View |
Ownership |
2021-07-27 9:58 pm |
N/A N/A |
DA32 Life Science Tech Acquisition Corp. | DALS | ARCH Venture Fund XI L.P. ARCH Venture Partners XI L.P. ARCH Venture Partners XI LLC NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner |
0 | $0 | 5,166,250 (Indirect) |
View |
| 2021-07-20 Conversion |
2021-07-20 8:53 pm |
N/A N/A |
Erasca Inc. | ERAS | ARCH Venture Partners X LLC ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. NELSEN ROBERT CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner |
18,794,443 | $0 | 5,527,777 (Indirect) |
View |
Ownership |
2021-07-15 9:06 pm |
N/A N/A |
Erasca Inc. | ERAS | ARCH Venture Partners X LLC ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. NELSEN ROBERT CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner |
0 | $0 | 11,055,554 (Indirect) |
View |
| 2021-06-30 Other |
2021-07-02 5:20 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Burow Kristina Director |
202,011 | $0 | 3,335,597 (Indirect) |
View |
| 2021-06-25 Other |
2021-06-29 5:20 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Burow Kristina Director |
404,022 | $0 | 3,935,597 (Indirect) |
View |
| 2021-06-24 Option Award |
2021-06-28 5:12 pm |
N/A 2031-06-23 |
Unity Biotechnology Inc. | UBX | Burow Kristina Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-06-21 Conversion |
2021-06-23 4:29 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | ARCH Venture Partners X LLC ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. CRANDELL KEITH NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner |
25,739,146 | $0 | 1,254,405 (Indirect) |
View |
Ownership |
2021-06-16 7:35 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Partners X LLC CRANDELL KEITH NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner |
0 | $0 | 2,508,809 (Indirect) |
View |
| 2021-06-10 Option Award |
2021-06-14 07:55 am |
N/A 2031-06-10 |
Beam Therapeutics Inc. | BEAM | Burow Kristina Director |
6,877 | $0 | 6,877 (Direct) |
View |
| 2021-06-09 Option Award |
2021-06-10 9:01 pm |
N/A 2031-06-08 |
Gossamer Bio Inc. | GOSS | Burow Kristina Director |
23,500 | $0 | 23,500 (Direct) |
View |
| 2021-05-27 Option Award |
2021-06-01 5:03 pm |
N/A 2031-05-27 |
Scholar Rock Holding Corp | SRRK | Burow Kristina Director |
7,800 | $0 | 7,800 (Direct) |
View |
| 2021-05-24 Option Award |
2021-05-25 6:58 pm |
N/A 2031-05-23 |
Metacrine Inc. | MTCR | Burow Kristina Director |
16,500 | $0 | 16,500 (Direct) |
View |
| 2021-03-31 Other |
2021-04-02 3:21 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Burow Kristina Director |
202,011 | $0 | 3,929,564 (Indirect) |
View |
| 2021-03-18 Other |
2021-03-22 7:37 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Burow Kristina Director |
404,023 | $0 | 4,529,565 (Indirect) |
View |
| 2021-02-08 Conversion |
2021-02-10 7:22 pm |
N/A N/A |
Sana Biotechnology Inc. | SANA | ARCH Venture Fund X L.P. CRANDELL KEITH BYBEE CLINTON Burow Kristina GILLIS STEVEN 10% Owner |
65,625,000 | $0 | 11,718,750 (Indirect) |
View |
Ownership |
2021-02-03 9:30 pm |
N/A N/A |
Sana Biotechnology Inc. | SANA | ARCH Venture Fund X L.P. CRANDELL KEITH BYBEE CLINTON Burow Kristina GILLIS STEVEN 10% Owner |
0 | $0 | 44,042,500 (Indirect) |
View |
| 2020-09-18 Conversion |
2020-09-22 11:09 am |
N/A N/A |
Metacrine Inc. | MTCR | Burow Kristina Director |
2,710,503 | $0 | 158,734 (Indirect) |
View |
Ownership |
2020-09-15 5:03 pm |
N/A N/A |
Metacrine Inc. | MTCR | Burow Kristina Director |
0 | $0 | 2,710,503 (Indirect) |
View |